Anti‐VEGF vs control
Vision‐related quality of life · people with neovascular age‐related macular degeneration
Summary of findings: anti‐VEGF treatment probably leads to higher mean change in vision‐related quality of life compared with control (moderate certainty).
1 finding from 1 review
- Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration 2019 · Cochrane Headline outcomes onlyMD 6.69 [3.38, 9.99]2 studies · 1134 participantsModerate